APPLICATION
ANDA087060
TYPE
ANDA
ORIGINAL APPROVAL
1980-11-05
LATEST ACTION
2023-10-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
HYDROCHLOROTHIAZIDEDiscontinued
HYDROCHLOROTHIAZIDE 100MG · TABLET · ORAL
Approval history
2023-10-23Labeling · Supplement 3 · standardAP
2020-08-20Labeling · Supplement 2 · standardAP
1995-08-03Labeling · Supplement 1AP
1980-11-05OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.